National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Bristol-Myers-Squibb

Therapeutic Approach

Injectables

Indication

Psoriatic Arthritis

Mechanism

immune suppressant (prevents T-cell activation)

Phase

Phase III

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.